USP18 downregulation in peripheral blood mononuclear cells predicts nonresponse to interferon-based triple therapy in patients with chronic hepatitis C, genotype 1: a pilot study

References

• CookeGSLemoineMThurszMViral hepatitis and the Global Burden of Disease: a need to regroupJ Viral Hepat201320960060123910643
   PubMed Web of Science ®Google Scholar
• ThimmeRBinderMBartenschlagerRFailure of innate and adaptive immune responses in controlling hepatitis C virus infectionFEMS Microbiol Rev201236366368322142141
   PubMed Web of Science ®Google Scholar
• BolenCRRobekMDBrodskyLThe blood transcriptional signature of chronic hepatitis C virus is consistent with an ongoing interferon-mediated antiviral responseJ Interferon Cytokine Res2013331152323067362
   PubMed Web of Science ®Google Scholar
• ChenLBorozanIFeldJHepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infectionGastroenterology200512851437144415887125
   PubMed Web of Science ®Google Scholar
• AsselahTBiecheINarguetSLiver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis CGut200857451652417895355
   PubMed Web of Science ®Google Scholar
• HouJvan OordGGroothuisminkZMGene expression profiling to predict and assess the consequences of therapy-induced virus eradication in chronic hepatitis C virus infectionJ Virol20148821122541226425100847
   PubMed Web of Science ®Google Scholar
• JiXCheungRCooperSLiQGreenbergHBHeXSInterferon alfa regulated gene expression in patients initiating interferon treatment for chronic hepatitis CHepatology200337361062112601359
   PubMed Web of Science ®Google Scholar
• McHutchisonJGLawitzEJShiffmanMLPeginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infectionN Engl J Med2009361658059319625712
   PubMed Web of Science ®Google Scholar
• Sarasin-FilipowiczMOakeleyEJDuongFHInterferon signaling and treatment outcome in chronic hepatitis CProc Natl Acad Sci U S A2008105197034703918467494
   PubMed Web of Science ®Google Scholar
• ChenLBorozanISunJCell-type specific gene expression signature in liver underlies response to interferon therapy in chronic hepatitis C infectionGastroenterology2010138311231133e1121e112319900446
   PubMed Web of Science ®Google Scholar
• TaylorMWTsukaharaTMcClintickJNEdenbergHJKwoPCyclic changes in gene expression induced by Peg-interferon alfa-2b plus ribavirin in peripheral blood monocytes (PBMC) of hepatitis C patients during the first 10 weeks of treatmentJ Transl Med200866618986530
   PubMed Web of Science ®Google Scholar
• MacParlandSACorkumCPBurgessCKarwowskaSKrollWMichalakTIDifferential expression of interferon alpha inducible genes in peripheral blood mononuclear cells from patients chronically infected with hepatitis C virus and healthy donorsInt Immunopharmacol201525254555225765354
   PubMed Web of Science ®Google Scholar
• FabrisCFalletiECussighAIL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCCJ Hepatol201154471672221146242
   PubMed Web of Science ®Google Scholar
• HeQGrahamCSDurante MangoniEKozielMJDifferential expression of toll-like receptor mRNA in treatment non-responders and sustained virologic responders at baseline in patients with chronic hepatitis CLiver Int20062691100111017032411
   PubMed Web of Science ®Google Scholar
• RehermannBChronic infections with hepatotropic viruses: mechanisms of impairment of cellular immune responsesSemin Liver Dis200727215216017520515
   PubMed Web of Science ®Google Scholar
• HotterDSauterDKirchhoffFEmerging role of the host restriction factor tetherin in viral immune sensingJ Mol Biol2013425244956496424075872
   PubMed Web of Science ®Google Scholar
• Prokunina-OlssonLMuchmoreBTangWA variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virusNature Genet201345216417123291588
   PubMed Web of Science ®Google Scholar
• HondaMSakaiAYamashitaTHepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis CGastroenterology2010139249950920434452
   PubMed Web of Science ®Google Scholar
• DillMTDuongFHVogtJEInterferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis CGastroenterology201114031021103121111740
   PubMed Web of Science ®Google Scholar
• AmanzadaAKoppWSpenglerURamadoriGMihmSInterferon-lambda 4 (IFNL4) transcript expression in human liver tissue samplesPLoS One2013812e8402624376784
   PubMed Web of Science ®Google Scholar
• BordiLCagliotiCGarbugliaARIFNL4 and IFNL3 associated polymorphisms strongly influence the spontaneous IFN-alpha receptor-1 expression in HCV-infected patientsPLoS One2015102e011739725675103
   PubMed Web of Science ®Google Scholar
• RallonNILopez-FernandezLAGarciaMIInterferon-stimulated genes are associated with peginterferon/ribavirin treatment response regardless of IL28B alleles in hepatitis C virus/HIV-coinfected patientsAids201327568769623196939
   PubMed Web of Science ®Google Scholar
• ReddyKRZeuzemSZoulimFSimeprevir versus telaprevir with peginterferon and ribavirin in previous null or partial responders with chronic hepatitis C virus genotype 1 infection (ATTAIN): a randomised, double-blind, non-inferiority phase 3 trialLancet Infect Dis2015151273525482330
   PubMed Web of Science ®Google Scholar
• MalakhovaOAYanMMalakhovMPProtein ISGylation modulates the JAK-STAT signaling pathwayGenes Dev200317445546012600939
   PubMed Web of Science ®Google Scholar
• MalakhovaOAKimKILuoJKUBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activityEMBO J200625112358236716710296
   PubMed Web of Science ®Google Scholar
• RandallGChenLPanisMSilencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infectionGastroenterology200613151584159117101330
   PubMed Web of Science ®Google Scholar
• ChuaPKMcCownMFRajyaguruSModulation of alpha interferon anti-hepatitis C virus activity by ISG15J Gen Virol200990Pt 122929293919656964
   PubMedGoogle Scholar